Neuromodulation for COVID-19 update 3: Open trials for Long-Covid

This is the third update (Nov 2021) on the use of Neuromodulation for COVID-19 as part of Neuromodec’s initiative to educate on and advance treatments.

November 28th, 2021

NeuroPace received FDA nod for IDE trial on closed-loop neuromodulation therapy for idiopathic generalized epilepsy (IGE)

NeuroPace has received an investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) allowing is to proceed...

November 16th, 2021

National Institutes of Health (NIH) award team of medical centers $10m to test Synchron brain interface technology

The National Institutes of Health (NIH) awarded Mount Sinai Health System, Carnegie Mellon University, University of Pittsburgh Medical Center (UPMC), and Synchron Inc. with $10 millio...

September 5th, 2021

Neuromodulation plus Digital Therapeutics

Digital Therapeutics spans technologies that rely on web or app-based interfaces to deliver guided audio and video for therapeutic or wellness purposes...

July 6th, 2021

NYU Langone Hospital Announces At-Home Virtual Brain Stimulation Program

The NYU Langone Health medical system announced at-home service for non-invasive (wearable) neuromodulation...

May 30th, 2021

Image credit: NYU Langone

Tivic Health Accelerates Wearable Neuromodulation with Consumers in Mind

Tivic Health sponsored a series of studies of its ClearUP. The results, as summarized by the company include reduction sinus pain in about 75% participants...

April 10th, 2021

Neuromodec Monthly Update - March 2021

The event will be held over four half days, with two am sessions and two pm sessions. It will feature international and national keynote speakers, symposia and talks by brain stimulation researchers...

March 15, 2021

Neurolief announces FDA clearance and Japan partnership

Neurolief announces FDA clearance and Japan partnership Neurolief today announced that it received FDA clearance for its Relivion noninvasive neuromodulation system

March 4, 2021

Safety and Efficacy of Adaptive Deep Brain Stimulation

The event will be held over four half days, with two am sessions and two pm sessions. It will feature international and national keynote speakers, symposia and talks by brain stimulation researchers...

February 16^nd, 2021